Skip to search formSkip to main contentSkip to account menu

Climara

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Estradiol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
INDIVIDUALIZATION OF CUSTOM COMPOUNDED HORMONE THERAPY IN A PATIENT WITH CHEMOTHERAPY INDUCED PREMATURE OVARIAN INSUFFICIENCY AND IMPAIRED LIVER FUNCTION – CASE REPORT
SUMMARY Although the use of commercially manufactured hormone therapy (HT) to treat menopausal symptoms has declined during the… 
2012
2012
Therapy with climara in surgical menopause.
UNLABELLED Hormone replacement therapy in surgical menopause is a prophylactic measure that is used for preventing the short and… 
2007
2007
Simultaneous Estradiol and Levonorgestrel Transdermal Delivery from a 7-day Patch: In Vitro and In Vivo Drug Deliveries of Three Formulations
ABSTRACT A new drug-in-adhesive transdermal patch was developed to deliver both estradiol and levonorgestrel through the skin… 
2002
2002
Post-abortion depot medroxyprogesterone acetate continuation rates: a randomized trial of cyclic estradiol.
2002
2002
Effect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal women
Hormone replacement therapy (HRT) was considered as main prevention of cardiovascular disease (CVD) in postmenopausal women… 
2000
2000
The effect of site of application on the transcutaneous absorption of 17‐&bgr; estradiol from a transdermal delivery system (Climara)
Objective: The effect of site of application of 17‐&bgr; estradiol bioavailability was assessed in an open‐label, randomized… 
2000
2000
Bioavailability of estradiol from two matrix transdermal delivery systems: Menorest and Climara.
2000
2000
Drug concentration effect relationship of estradiol from two matrix transdermal delivery systems: Menorest and Climara.
1998
1998
Steady‐State Bioavailability of Estradiol from Two Matrix Transdermal Delivery Systems, Alora and Climara
The relative bioavailability of estradiol from two matrix transdermal delivery systems, Alora (0.05 mg/day when applied for 3–4… 
Highly Cited
1995
Highly Cited
1995
Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)